Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

daiichi sankyo europe gmbh - amlodipin; hidroklorotiazid; medoksomilolmesartanat - filmsko obložena tableta - amlodipin 10 mg / 1 tableta  hidroklorotiazid25 mg / 1 tableta  medoksomilolmesartanat40 mg / 1 tableta; hidroklorotiazid 25 mg / 1 tableta  medoksomilolmesartanat40 mg / 1 tableta; medoksomilolmesartanat 40 mg / 1 tableta - medoksomilolmesartanat, amlodipin in hidroklorotiazid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

daiichi sankyo europe gmbh - amlodipin; hidroklorotiazid; medoksomilolmesartanat - filmsko obložena tableta - amlodipin 5 mg / 1 tableta  hidroklorotiazid12,5 mg / 1 tableta  medoksomilolmesartanat40 mg / 1 tableta; hidroklorotiazid 12,5 mg / 1 tableta  medoksomilolmesartanat40 mg / 1 tableta; medoksomilolmesartanat 40 mg / 1 tableta - medoksomilolmesartanat, amlodipin in hidroklorotiazid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

daiichi sankyo europe gmbh - amlodipin; hidroklorotiazid; medoksomilolmesartanat - filmsko obložena tableta - amlodipin 5 mg / 1 tableta  hidroklorotiazid25 mg / 1 tableta  medoksomilolmesartanat40 mg / 1 tableta; hidroklorotiazid 25 mg / 1 tableta  medoksomilolmesartanat40 mg / 1 tableta; medoksomilolmesartanat 40 mg / 1 tableta - medoksomilolmesartanat, amlodipin in hidroklorotiazid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fresenius kabi austria gmbh. - propofol - emulzija za injiciranje/infundiranje - propofol 10 mg / 1 ml - propofol

Evropska unija - slovenščina - EMA (European Medicines Agency)

passauer pharma gmbh - mofetilmikofenolat - zavrnitev presadka - imunosupresivi - myclausen je indiciran v kombinaciji s ciklosporinom in kortikosteroidi za profilakso akutne zavrnitve presadka pri bolnikih, ki so prejemali alogenske ledvične, srčne ali jetrne presaditve.

Evropska unija - slovenščina - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

angelini pharma Ősterreich gmbh - fentanil - podjezična tableta - fentanil 133 µg / 1 tableta - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

angelini pharma Ősterreich gmbh - fentanil - podjezična tableta - fentanil 133 µg / 1 tableta - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

angelini pharma Ősterreich gmbh - fentanil - podjezična tableta - fentanil 133 µg / 1 tableta - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

angelini pharma Ősterreich gmbh - fentanil - podjezična tableta - fentanil 133 µg / 1 tableta - fentanil